Evidence map›Paper›PMID 26461968›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2015

Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients.

K A Newell, A Asare, I Sanz, C Wei, A Rosenberg, Z Gao, S Kanaparthi, S Asare, N Lim, M Stahly and 13 more

Registry-linked trialOpen access · hybridAbstract readComparative Study
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01338779 (Identification and Mechanistic Investigations of Tolerant Transplant Recipients), which is not on this map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01338779 completednot on this map

Identification and Mechanistic Investigations of Tolerant Transplant Recipients

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2004 to 2015Enrolled197ConditionsTransplant Rejection, Kidney Transplantation, Renal Transplantation, Renal Transplant
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Rise of a CD27European journal of immunology · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Apoptotic Donor Cells in Transplantation.Frontiers in immunology · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. B cell reconstitution following alemtuzumab induction under a belatacept-based maintenance regimen.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Article
  18. Article
  19. B cells in transplant tolerance and rejection: friends or foes?Transplant international : official journal of the European Society for Organ Transplantation · 2020
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 1 country.

K A NewellDepartment of Surgery, Emory University, Atlanta, GA.
A AsareImmune Tolerance Network, Bethesda, MD.
I SanzDepartment of Surgery, Emory University, Atlanta, GA.
C WeiDepartment of Surgery, Emory University, Atlanta, GA.
A RosenbergDepartment of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Z GaoCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
S KanaparthiImmune Tolerance Network, Bethesda, MD.
S AsareImmune Tolerance Network, Bethesda, MD.
N LimImmune Tolerance Network, Bethesda, MD.
M StahlyImmune Tolerance Network, Bethesda, MD.
M HowellImmune Tolerance Network, Bethesda, MD.
S KnechtleDepartment of Surgery, Emory University, Atlanta, GA.
A KirkDepartment of Surgery, Emory University, Atlanta, GA.
W H MarksSwedish Medical Center, Seattle, WA.
T KawaiCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
T SpitzerDepartment of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
N Tolkoff-RubinDepartment of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
M SykesDepartments of Medicine, and Microbiology and Immunology, Columbia University College of Physicians and Surgeons, New York, NY.
D H SachsCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
A B CosimiCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
W J BurlinghamDepartment of Surgery, University of Wisconsin, Madison, WI.
D PhippardImmune Tolerance Network, Bethesda, MD.
L A TurkaImmune Tolerance Network, Bethesda, MD.
Harvard University · USEmory University · USMassachusetts General Hospital · USImmune Tolerance Network · USColumbia University · USSwedish Medical Center · USUniversity of Rochester · USUniversity of Wisconsin–Madison · US

Funding

Immune Tolerance Network UM1 2023 SupplementUM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · 2014 to 2026
$451.6M
Regulation of B cell Responses in SLE and Other Autoimmune DiseasesU19AI110483 · NIAID · EMORY UNIVERSITY · PI Ignacio E. Sanz · 2014 to 2026
$76.6M
Role of B Cells in Synovial Inflammation & LN Remodeling in RA ArthritisP01AI078907 · NIAID · UNIVERSITY OF ROCHESTER · PI LUND, FRANCES E. · 2010 to 2014
$10.8M
Project-004U54CA260563 · NCI · EMORY UNIVERSITY · PI DHODAPKAR, MADHAV V, SANZ, IGNACIO E. · 2020 to 2024
$10.2M
A Model System for the Study of Human B-cell ToleranceR37AI049660 · NIAID · UNIVERSITY OF ROCHESTER · PI SANZ, IGNACIO E. · 2010 to 2019
$3.7M
IMMUNE TOLERANCE NETWORK-266015416-266015416N01AI015416 · NIAID · REGENTS OF THE UNIVERSITY OF C · PI BLUESTONE, JEFFREY A · 2002 to 2006
–
NCI NIH HHS U54 CA260563NIAID NIH HHS N01 AI015416NIAID NIH HHS P01 AI078907NIAID NIH HHS R37 AI049660NIAID NIH HHS U19 AI110483NIAID NIH HHS UM1 AI-109565NIAID NIH HHS UM1 AI109565
6 · The paper itself

Abstract

Biomarkers of transplant tolerance would enhance the safety and feasibility of clinical tolerance trials and potentially facilitate management of patients receiving immunosuppression. To this end, we examined blood from spontaneously tolerant renal transplant recipients and patients enrolled in two interventional tolerance trials using flow cytometry and gene expression profiling. Using a previously reported tolerant cohort as well as newly identified tolerant patients, we confirmed our previous finding that tolerance was associated with increased expression of B cell-associated genes relative to immunosuppressed patients. This was not accounted for merely by an increase in total B cell numbers, but was associated with the increased frequencies of transitional and naïve B cells. Moreover, serial measurements of gene expression demonstrated that this pattern persisted over several years, although patients receiving immunosuppression also displayed an increase in the two most dominant tolerance-related B cell genes, IGKV1D-13 and IGLL-1, over time. Importantly, patients rendered tolerant via induction of transient mixed chimerism, and those weaned to minimal immunosuppression, showed similar increases in IGKV1D-13 as did spontaneously tolerant individuals. Collectively, these findings support the notion that alterations in B cells may be a common theme for tolerant kidney transplant recipients, and that it is a useful monitoring tool in prospective trials.

Indexed as

Gene Expression RegulationAdultAllograftsB-Cell Activating FactorB-LymphocytesFemaleFlow CytometryGene Expression ProfilingGraft RejectionGraft SurvivalHumansImmunologic MemoryKidney TransplantationLongitudinal StudiesMaleMiddle AgedB-Cell Activating FactorTNFSF13B protein, human

Identifiers

PMID26461968
PMCPMC4725587
OpenAlexW1928653608

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.